3D printing and 3D bioprinting technology in medicine: ethical and legal issues

There has been a surge of interest in new technologies in medicine because of their promising clinical applications. Extensive research on additive manufacturing and its applications in the medical field has been carried out with good results and very high expectations. Due to their disruptive natur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica terapeutica 2023-01, Vol.174 (1), p.80-84
Hauptverfasser: Rizzo, M L, Turco, S, Spina, F, Costantino, A, Visi, G, Baronti, A, Maiese, A, Di Paolo, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 84
container_issue 1
container_start_page 80
container_title Clinica terapeutica
container_volume 174
creator Rizzo, M L
Turco, S
Spina, F
Costantino, A
Visi, G
Baronti, A
Maiese, A
Di Paolo, M
description There has been a surge of interest in new technologies in medicine because of their promising clinical applications. Extensive research on additive manufacturing and its applications in the medical field has been carried out with good results and very high expectations. Due to their disruptive nature and potential, 3D printing and even more 3D bioprinting raise many ethical and safety concerns that need to be adequately addressed to provide good regulation before entering clinical practice. This article aims to highlight the general ethical concerns associated with the use of additive manufacturing in medicine and the lack of current international regulatory directives to guide these experiments. Transparency about how these new medical devices are regulated and approved is a fundamental requirement to promote and improve public trust, efficiency, safety and quality.
doi_str_mv 10.7417/CT.2023.2501
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2767171983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2767171983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c169t-c95ba95ab650c80afcf68919c204daef882071799e3d23ea6ef4a343a5d218b33</originalsourceid><addsrcrecordid>eNo9UDtPwzAQtpAQLYWNGXlkSfAjtmM2FMpDqtSlzJHjXFIjxylxMvTfE6Aw3Xen76HvELqhJFUZVffFLmWE8ZQJQs_QkmrFEkmIWqDLGD8IEZpRfoEWXEohZKaXaMuf8GFwYXShxSbUeN4r1_-fRrD70Pu-PWIXcAe1sy7AA4Zx76zxPxIP7YxcjBPEK3TeGB_h-jRX6P15vStek8325a143CSWSj0mVovKaGEqKYjNiWlsI3NNtWUkqw00ec6Iokpr4DXjYCQ0meEZN6JmNK84X6G7X9_D0H_OuWPZuWjBexOgn2LJlJz1VOff1NsTdarmAuXcrTPDsfx7Av8CgNdbLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767171983</pqid></control><display><type>article</type><title>3D printing and 3D bioprinting technology in medicine: ethical and legal issues</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Rizzo, M L ; Turco, S ; Spina, F ; Costantino, A ; Visi, G ; Baronti, A ; Maiese, A ; Di Paolo, M</creator><creatorcontrib>Rizzo, M L ; Turco, S ; Spina, F ; Costantino, A ; Visi, G ; Baronti, A ; Maiese, A ; Di Paolo, M</creatorcontrib><description>There has been a surge of interest in new technologies in medicine because of their promising clinical applications. Extensive research on additive manufacturing and its applications in the medical field has been carried out with good results and very high expectations. Due to their disruptive nature and potential, 3D printing and even more 3D bioprinting raise many ethical and safety concerns that need to be adequately addressed to provide good regulation before entering clinical practice. This article aims to highlight the general ethical concerns associated with the use of additive manufacturing in medicine and the lack of current international regulatory directives to guide these experiments. Transparency about how these new medical devices are regulated and approved is a fundamental requirement to promote and improve public trust, efficiency, safety and quality.</description><identifier>EISSN: 1972-6007</identifier><identifier>DOI: 10.7417/CT.2023.2501</identifier><identifier>PMID: 36655649</identifier><language>eng</language><publisher>Italy</publisher><subject>Bioprinting - methods ; Humans ; Printing, Three-Dimensional ; Tissue Engineering - methods</subject><ispartof>Clinica terapeutica, 2023-01, Vol.174 (1), p.80-84</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c169t-c95ba95ab650c80afcf68919c204daef882071799e3d23ea6ef4a343a5d218b33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36655649$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rizzo, M L</creatorcontrib><creatorcontrib>Turco, S</creatorcontrib><creatorcontrib>Spina, F</creatorcontrib><creatorcontrib>Costantino, A</creatorcontrib><creatorcontrib>Visi, G</creatorcontrib><creatorcontrib>Baronti, A</creatorcontrib><creatorcontrib>Maiese, A</creatorcontrib><creatorcontrib>Di Paolo, M</creatorcontrib><title>3D printing and 3D bioprinting technology in medicine: ethical and legal issues</title><title>Clinica terapeutica</title><addtitle>Clin Ter</addtitle><description>There has been a surge of interest in new technologies in medicine because of their promising clinical applications. Extensive research on additive manufacturing and its applications in the medical field has been carried out with good results and very high expectations. Due to their disruptive nature and potential, 3D printing and even more 3D bioprinting raise many ethical and safety concerns that need to be adequately addressed to provide good regulation before entering clinical practice. This article aims to highlight the general ethical concerns associated with the use of additive manufacturing in medicine and the lack of current international regulatory directives to guide these experiments. Transparency about how these new medical devices are regulated and approved is a fundamental requirement to promote and improve public trust, efficiency, safety and quality.</description><subject>Bioprinting - methods</subject><subject>Humans</subject><subject>Printing, Three-Dimensional</subject><subject>Tissue Engineering - methods</subject><issn>1972-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UDtPwzAQtpAQLYWNGXlkSfAjtmM2FMpDqtSlzJHjXFIjxylxMvTfE6Aw3Xen76HvELqhJFUZVffFLmWE8ZQJQs_QkmrFEkmIWqDLGD8IEZpRfoEWXEohZKaXaMuf8GFwYXShxSbUeN4r1_-fRrD70Pu-PWIXcAe1sy7AA4Zx76zxPxIP7YxcjBPEK3TeGB_h-jRX6P15vStek8325a143CSWSj0mVovKaGEqKYjNiWlsI3NNtWUkqw00ec6Iokpr4DXjYCQ0meEZN6JmNK84X6G7X9_D0H_OuWPZuWjBexOgn2LJlJz1VOff1NsTdarmAuXcrTPDsfx7Av8CgNdbLg</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Rizzo, M L</creator><creator>Turco, S</creator><creator>Spina, F</creator><creator>Costantino, A</creator><creator>Visi, G</creator><creator>Baronti, A</creator><creator>Maiese, A</creator><creator>Di Paolo, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202301</creationdate><title>3D printing and 3D bioprinting technology in medicine: ethical and legal issues</title><author>Rizzo, M L ; Turco, S ; Spina, F ; Costantino, A ; Visi, G ; Baronti, A ; Maiese, A ; Di Paolo, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c169t-c95ba95ab650c80afcf68919c204daef882071799e3d23ea6ef4a343a5d218b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bioprinting - methods</topic><topic>Humans</topic><topic>Printing, Three-Dimensional</topic><topic>Tissue Engineering - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rizzo, M L</creatorcontrib><creatorcontrib>Turco, S</creatorcontrib><creatorcontrib>Spina, F</creatorcontrib><creatorcontrib>Costantino, A</creatorcontrib><creatorcontrib>Visi, G</creatorcontrib><creatorcontrib>Baronti, A</creatorcontrib><creatorcontrib>Maiese, A</creatorcontrib><creatorcontrib>Di Paolo, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica terapeutica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rizzo, M L</au><au>Turco, S</au><au>Spina, F</au><au>Costantino, A</au><au>Visi, G</au><au>Baronti, A</au><au>Maiese, A</au><au>Di Paolo, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>3D printing and 3D bioprinting technology in medicine: ethical and legal issues</atitle><jtitle>Clinica terapeutica</jtitle><addtitle>Clin Ter</addtitle><date>2023-01</date><risdate>2023</risdate><volume>174</volume><issue>1</issue><spage>80</spage><epage>84</epage><pages>80-84</pages><eissn>1972-6007</eissn><abstract>There has been a surge of interest in new technologies in medicine because of their promising clinical applications. Extensive research on additive manufacturing and its applications in the medical field has been carried out with good results and very high expectations. Due to their disruptive nature and potential, 3D printing and even more 3D bioprinting raise many ethical and safety concerns that need to be adequately addressed to provide good regulation before entering clinical practice. This article aims to highlight the general ethical concerns associated with the use of additive manufacturing in medicine and the lack of current international regulatory directives to guide these experiments. Transparency about how these new medical devices are regulated and approved is a fundamental requirement to promote and improve public trust, efficiency, safety and quality.</abstract><cop>Italy</cop><pmid>36655649</pmid><doi>10.7417/CT.2023.2501</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1972-6007
ispartof Clinica terapeutica, 2023-01, Vol.174 (1), p.80-84
issn 1972-6007
language eng
recordid cdi_proquest_miscellaneous_2767171983
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Bioprinting - methods
Humans
Printing, Three-Dimensional
Tissue Engineering - methods
title 3D printing and 3D bioprinting technology in medicine: ethical and legal issues
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A39%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=3D%20printing%20and%203D%20bioprinting%20technology%20in%20medicine:%20ethical%20and%20legal%20issues&rft.jtitle=Clinica%20terapeutica&rft.au=Rizzo,%20M%20L&rft.date=2023-01&rft.volume=174&rft.issue=1&rft.spage=80&rft.epage=84&rft.pages=80-84&rft.eissn=1972-6007&rft_id=info:doi/10.7417/CT.2023.2501&rft_dat=%3Cproquest_pubme%3E2767171983%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2767171983&rft_id=info:pmid/36655649&rfr_iscdi=true